| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/15/2008 | CA2289086C Methods for using macrocyclic lactone compounds as multidrug resistance reversing agents in tumor and other cells |
| 07/15/2008 | CA2283327C Cationic lipid compositions targeting angiogenic endothelial cells |
| 07/15/2008 | CA2271857C Method for treating symptoms of diabetes |
| 07/15/2008 | CA2247848C Nitric oxide donors capable of reducing toxicity from drugs |
| 07/15/2008 | CA2245637C Antipsoriatic nail polish |
| 07/15/2008 | CA2213612C Composition for controlling parasites |
| 07/15/2008 | CA2207103C Methods to identify hemochromatosis |
| 07/15/2008 | CA2149329C Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 07/10/2008 | WO2008081914A1 Novel aminopyrimidine derivative as plk1 inhibitor |
| 07/10/2008 | WO2008081732A1 Animal model of schizophrenia or cognitive impairment, screening method using the same and preventive or therapeutic agent for schizophrenia or cognitive impairment |
| 07/10/2008 | WO2008081035A1 Anti-tumor vaccine derived from normal chemically modified cells |
| 07/10/2008 | WO2008080980A1 Medicinal composition for treating animal skin comprising a wound healing agent and a deterrent |
| 07/10/2008 | WO2008040774A3 Angiotensin ii receptor antagonist for the treatment of systemic diseases in cats |
| 07/10/2008 | WO2002102229A9 Diagnosing tumorigenicity and determining resistance to anticancer therapy |
| 07/10/2008 | US20080168573 Transgenic worms for use as bioreactor for expression of carboxylesterase-1for use in treatment of alzheimer's disease |
| 07/10/2008 | US20080167513 Strontium-Containing Compounds for Use in the Prevention or Treatment of Necrotic Bone Conditions |
| 07/10/2008 | US20080167457 Nonhuman model animal lacking the ability to control lymphocyte migration |
| 07/10/2008 | US20080167388 Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis |
| 07/10/2008 | US20080167387 Microglia Facilitated Amyloidogenesis Assay |
| 07/10/2008 | US20080167365 Of the ACE inhibitor ramipril by mixing with the ramipril (m)ethyl ester prodrug and a pressure sensitive adhesive carrier; improved pharmacokinetics; sustained release |
| 07/10/2008 | US20080167310 Syndrome X, antidiabetic agents; hypoglycemic agents;antilipemic agents; artherosclerosis; cardiovascular disorders |
| 07/10/2008 | US20080167280 Enhanced drug delivery in transdermal systems |
| 07/10/2008 | US20080167255 4-biarylyl-1-phenylazetidin-2-ones |
| 07/10/2008 | US20080167230 treating asthma by administering a trefoil peptide, the human intestinal trefoil factor (ITF), cyclic peptides |
| 07/10/2008 | US20080167217 Aryl ketone compounds and compositions for delivering active agents |
| 07/10/2008 | US20080166768 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof |
| 07/10/2008 | US20080166743 Trp8, a transient receptor potential channel expressed in taste receptor cells |
| 07/10/2008 | US20080166724 VEGF-Modulated Genes and Methods Employing Them |
| 07/10/2008 | US20080166709 MARKs as Modifiers of the p53 Pathway and Methods of Use |
| 07/10/2008 | US20080166433 Methods and Composition For Dietary Supplements |
| 07/10/2008 | US20080166428 Utilizing glutathione S transferase (GST) activated glutamyl-3-[[2-[[bis[bis(2-choroethyl)-amino]phosphinyl]oxy]ethyl]sulfonyl]-L-alanyl-2-phenyl-glycine (canfosfamide) |
| 07/10/2008 | US20080166427 Method for Reducing Gastrointestinal Toxicity Due to the Administration of Tegafur |
| 07/10/2008 | US20080166413 Topical pharmaceutical formulations and methods of treatment |
| 07/10/2008 | US20080166387 Anti-angiogenic compositions and methods of use |
| 07/10/2008 | US20080166386 Glycolic acid-lactic acid copolymers as bulking agent; soft tissue augmentation |
| 07/10/2008 | US20080166354 Using monoclonal antibody specific to inhibitor of protease or of a non-proteolytic matrix-degrading enzyme (IPNME) as therapeutic tool in treatment of cell proliferative disorders |
| 07/10/2008 | US20080166351 Kit comprising beacizumab and antitumor agents for use in treatment of metastatic colorectal cancer in a human |
| 07/10/2008 | US20080166318 Methods and therapeutic combinations for the treatment of demyelination |
| 07/10/2008 | CA2668738A1 Novel aminopyrimidine derivatives as plk1 inhibitors |
| 07/09/2008 | EP1942114A2 Mammalian cytokines; related reagents and methods |
| 07/09/2008 | EP1942108A1 Compound containing basic group and use thereof |
| 07/09/2008 | EP1941911A1 Method for prevention and/or treatment of rheumatoid arthritis |
| 07/09/2008 | EP1941910A1 Pharmaceutical form for the treatment of patients with acute cases and exacerbations of rheumatoid arthritis and related acute disorders |
| 07/09/2008 | EP1941909A1 Preventives/remedies for cancer |
| 07/09/2008 | EP1941908A1 Therapeutic agent for heart disease |
| 07/09/2008 | EP1941907A1 Inhibitor of transplanted islet dysfunction in islet transplantation |
| 07/09/2008 | EP1941906A1 Hepatic fibrosis inhibitor |
| 07/09/2008 | EP1941905A1 APO-2 Ligand-anti-her-2 antibody synergism |
| 07/09/2008 | EP1941894A1 Isoflavone composition for the treatment of menopausal physiological disorders and symptoms |
| 07/09/2008 | EP1941878A1 Sedative non-benzodiazepine formulations |
| 07/09/2008 | EP1941873A1 Metallo-beta-lactamase inhibitor |
| 07/09/2008 | EP1941872A1 Use of TNF-alpha inhibitors for treating nerve root injury |
| 07/09/2008 | EP1941870A2 Perfume Composition comprising perilla aldehyde |
| 07/09/2008 | EP1941829A2 Noninvasive measurement of chemical substances |
| 07/09/2008 | EP1940444A2 Methods of preparing targeted immunoliposomes |
| 07/09/2008 | EP1940428A1 Bile preparations for gastrointestinal disorders |
| 07/09/2008 | EP1940417A2 Method of treating clostridium difficile-associated diarrhea |
| 07/09/2008 | EP1940414A2 Anti mineralocorticoid therapy of infection |
| 07/09/2008 | EP1940408A1 ADENOSINE A2a RECEPTOR ANTAGONISTS FOR THE TREATMENT OF EXTRA-PYRAMIDAL SYNDROME AND OTHER MOVEMENT DISORDERS |
| 07/09/2008 | EP1940389A2 Modulation of neurogenesis by pde inhibition |
| 07/09/2008 | EP1940374A2 Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent |
| 07/09/2008 | EP1539136B1 Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders |
| 07/09/2008 | EP1534289B1 Adenosine a2a receptor antagonists for treating restless legs syndrome or nocturnal myoclonus |
| 07/09/2008 | EP1523571B1 Sgk and nedd used as diagnostic and therapeutic targets |
| 07/09/2008 | EP1492577B1 Film-forming compositions for protecting skin from body fluids and articles made therefrom |
| 07/09/2008 | EP1469858B1 Non-nucleosidic inhibitors of reverse transcriptase as antagonists of cell proliferation and inducers of cell differentiation |
| 07/09/2008 | EP1465863B1 Potassium channel modulators |
| 07/09/2008 | EP1427391B1 Solid-phase agent for vascular occlusion with immobilised platelet binding agent |
| 07/09/2008 | EP1408109B1 Novel method for the induction of cellular senescence and method for screening anti-aging agent |
| 07/09/2008 | EP1392348B1 Treatment of dementia and neurodegenerative diseases with intermediate doses of lhrh antagonists |
| 07/09/2008 | EP1385499B1 Use of carnitine for the preparation of an injection solution for preventing or alleviating ascites in poultry by in-ovo injection |
| 07/09/2008 | EP1381345B1 Delivery of disease control in aquaculture using yeasts containing bioactive proteins |
| 07/09/2008 | EP1370243B1 Method to obtain microparticles containing a h+, k+ -atp-ase inhibitor |
| 07/09/2008 | EP1303304B1 Pharmaceutical combinations for treatment and prevention of diabetes mellitus |
| 07/09/2008 | EP1286674B1 Composition for potentiating cancer chemotherapeutic agents |
| 07/09/2008 | EP1234185B1 Pin1 as a marker of the stage of agressiveness and/or metastasis of abnormal cell growth |
| 07/09/2008 | EP1234041B1 Methods for cell screening of compounds capable of modulating the activity of ubiquitin-ligase scf complexes and their uses |
| 07/09/2008 | EP1226177B1 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| 07/09/2008 | EP1220842B1 Cyclic amine compound as ccr5 antagonist |
| 07/09/2008 | EP1219624B1 Remedies for neuropathic pain and model animals of neuropathic pain |
| 07/09/2008 | EP1156820B1 Use of vascular endothelial growth factor-2 (vegf-2) |
| 07/09/2008 | EP0783577B1 Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases |
| 07/09/2008 | CN101217952A Composition for preventing occurrence of cardiovascular event |
| 07/09/2008 | CN101217870A Antimicrobial compositions containing synergistic combinations of quaternary ammonium compounds and essential oils and/or constituents thereof |
| 07/09/2008 | CN101215601A Effectors of innate immunity determination |
| 07/09/2008 | CN101214379A Novel composing prescription sustained-release preparation for treating high blood pressure and preparation method thereof |
| 07/09/2008 | CN101214249A Chaperone-based therapy for niemann-pick disease |
| 07/09/2008 | CN101214248A Triazolo[4,5-d] pyrimidine derivatives and their application as purinergic receptor antagonists |
| 07/09/2008 | CN101214245A Composition containing ciclacillin or its derivatives and preparation thereof |
| 07/09/2008 | CN101214220A Sustained-release injection containing amethopterin synergist |
| 07/09/2008 | CN100400504C Amide derivatives as inhibitors of the enzymatic activity of renin |
| 07/09/2008 | CN100400104C Polyvidone-phospholipid-cholate ternary composition used for difficult soluble medicine carrier |
| 07/09/2008 | CN100400103C Pharmaceutical composition |
| 07/09/2008 | CN100400046C Remedies for lung cancer |
| 07/08/2008 | US7396946 Compound for treatment of external secretion disorders |
| 07/08/2008 | US7396920 Tumour suppressor and uses thereof |
| 07/08/2008 | US7396910 Transient receptor potential channel TRPV3 and its use |
| 07/08/2008 | US7396826 prophylaxis/therapy of diabetes, inflammation, cancer, necrosis, gastric ulcers, neurodegenerative and neuropathic diseases, neuropathic pain, polyneuropathy using e.g. Octadeca-6,9,12-trienoic acid 5' -(2,4-dioxo-3,4-dihydro-2H-pyrimidine-1-yl)-3',4 dihydroxy-tetrahydrofuran-2'-yl methyl ester |
| 07/08/2008 | US7396811 Subcellular targeting of therapeutic proteins |
| 07/08/2008 | US7396809 Methods and reagents for treating glucose metabolic disorders |